pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
  1. pharmadog
  2. ›drugs
  3. ›Sinuva
drug · small molecule
save

mometasone furoate

Phase 2updated 3mo ago
by EsoCap AG🔗 ChEMBL
Phase 2
community read0 votes

🐶 often sniffed alongside

top 4
  • tagApproval6 co-mentions · 3 sources
  • drugElocon3 co-mentions · 3 sources
  • drugAsmanex HFA3 co-mentions · 3 sources
  • drugAsmanex Twisthaler3 co-mentions · 3 sources

Small molecule drug with a maximum clinical stage of Approval (across all indications), with 7 approved and 18 investigational indications.

targets

Glucocorticoid receptor

all catalysts(0)

nothing on the calendar yet

Trials studying mometasone furoate

  • phase3A Phase 3 Study to Assess the Efficacy, Safety, and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participants With Inadequately-controlled Chronic Rhinosinusitis With Nasal Polypsactive not recruitingn=216
  • phase3A Phase 3 Study to Assess the Efficacy, Safety, and Tolerability of Itepekimab (Anti-IL-33 mAb) in Participants With Inadequately-controlled Chronic Rhinosinusitis With Nasal Polypsrecruitingn=210
  • phase2Long-term Safety and Efficacy Evaluation of Lunsekimig in Adult Participants With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) Who Completed a Previous Lunsekimig CRSwNP Studyrecruitingn=64
  • phase3Efficacy and Safety of Tezepelumab in Participants With Severe Chronic Rhinosinusitis With Nasal Polyposiscompletedn=416
  • phase2A Proof-of-Concept Study to Assess the Efficacy, Safety and Tolerability of Itepekimab (Anti--IL-33 mAb) in Participants With Chronic Rhinosinusitis Without Nasal Polypsactive not recruitingn=60
  • phase2A Study of the Efficacy and Safety of Brensocatib in Participants With Chronic Rhinosinusitis Without Nasal Polyps (CRSsNP)completedn=288
  • phase3Effectiveness and Safety of Once or Twice Daily Mometasone Nasal Spray Versus Amoxicillin Versus Placebo for Treatment of Acute Rhinosinusitis (Phase 3 Study)(Study P02692)completedn=981
  • phase3A Long-term Study of Mometasone Furoate in Patients With Perennial Allergic Rhinitis (Study P04459)completedn=98
more trials →

News(0)

no news has mentioned this drug yet

brand
Sinuva
trade names
Asmanex, Asmanex hfa, Asmanex twisthaler, Elocon, Mometasone furoate, Mometasone furoate component of dulera
generic
mometasone furoate
MOA
Glucocorticoid receptor agonist
indication
Eosinophilic Esophagitis
phase
phase_2
Data sources
ClinicalTrials.gov · OpenTargets
last refreshed 3m ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?